B+L & Prevent Blindness Raising Awareness About Cataracts
Bausch + Lomb and Prevent Blindness joined forces for Cataract Awareness Month in June to educate the public and raise awareness about the symptoms and causes of, and treatment options for, cataracts. Throughout the month, Bausch + Lomb and Prevent Blindness will post content on their social media pages to share facts and information about cataracts and cataract surgery. Bausch + Lomb will donate $1 to Prevent Blindness for every Facebook “like” or “share” up to $50,000, from June 1 through June 30 to support education and advocacy work aimed at ensuring all people have access to cataract surgery and care. Visit Bausch + Lomb’s Facebook page.
Genetic Test Helps Determine Patient’s Risk of Keratoconus and Presence of Other Corneal Dystrophies
Avellino Lab announced US nationwide availability of AvaGen, The Genetic Eye Test, as the first genetic test that helps determine a patient’s risk of keratoconus and the presence of other corneal dystrophies. The test is designed to provide keratoconus patients with an earlier benefit from FDA-approved cross-linking treatment, which can halt disease progression and preserve vision. Read more.
Bausch Health and Clearside File Acceptance For Xipere
Bausch Health Companies along with Clearside Biomedical announced the FDA accepted the resubmitted New Drug Application for Xipere (triamcinolone acetonide suprachoroidal injectable suspension). The FDA determined the filing is a Class 2 resubmission and assigned a Prescription Drug User Fee Act (PDUFA) action date of October 30. Xipere is an investigational therapy with a proposed indication of treatment of macular edema associated with uveitis. Read more.
Luminopia One Offers Potential New Amblyopia Treatment
Luminopia One created an innovative therapeutic to treat amblyopia enabling kids to be treated at home by watching one hour per day of therapeutically modified content, including their favorite shows from Nickelodeon, Dreamworks and others, while wearing a VR headset. In a randomized controlled trial, findings revealed that Luminopia One may provide a new treatment alternative to patching and atropine for children with amblyopia. Luminopia One’s therapy, which has demonstrated in several clinical trials its effectiveness as an at-home treatment, is under review with the FDA. Read about some of the findings here and here. Learn more.
The Children’s Eye Foundation of AAPOS Debuts Interactive Storybook to Help Screen for Color Vision Deficiency
The Children’s Eye Foundation of AAPOS unveiled the world’s first interactive children’s book to help screen for color vision deficiency (CVD), commonly known as color blindness. The foundation posted a free digital version of at its website and published a first-run, hardcover book for its member pediatric ophthalmologists. Visit the site.
ISVA Announces Appointments Of New Executive And Advisory Board Officers
The International Sports Vision Association, an interdisciplinary group of professionals dedicated to advancing the field of vision training for athletes of all ages and levels to help them achieve peak athletic performance, announced appointments to its new Executive and Advisory Board. View the board members.
Prevent Blindness to Host 10th Annual Focus on Eye Health National Summit Virtually
Prevent Blindness will host the 10th annual Prevent Blindness Focus on Eye Health National Summit virtually July 14 to 15. This year’s Summit will include a variety of presentations related to the theme “Our Changing Vision.” During the event, Prevent Blindness will present the 2021 Jenny Pomeroy Award for Excellence in Vision and Public Health to R.V. Paul Chan, MD, MSc, MBA, FACS, professor and head, Department of Ophthalmology and Visual Sciences, the John H. Panton, MD Professor of Ophthalmology; and director, Pediatric Retina and ROP Service at the Illinois Eye and Ear Infirmary, University of Illinois at Chicago. Learn more.
ISVA and MacuHealth Offer Educational Resource on Sports Nutrition for Eyes
The International Sports Vision Association and MacuHealth launched Sports Nutrition for Your Eyes, a new educational resource on the ISVA website designed to help educate athletes about how proper nutrition can have preventive and protective benefits for overall well-being‚ improve their vision and eye health, and help enhance their sports performance. Read more.
Coburn Introduces New HFC-1 Fundus Camera
Coburn Technologies introduced the HFC-1 Non-Mydriatic Fundus Camera, a new retinal camera manufactured by Huvitz, with highly accurate autodetection technology for sharp, quick and reliable retinal imaging and measurements. Automated tracking and shooting allow the HFC-1 Fundus Camera to adjust modes quickly while measuring differing pupil sizes. Its 20-megapixel high-definition camera is designed to capture images with reduced motion artifacts and can enlarge images to study fine details. The new fundus Camera includes a variety of image modes: color, blue, red, red-free and cobalt which aid in examinations for glaucoma, RNFL, edema, pigmentary abnormalities and more. Read more.